Supplementary MaterialsMultimedia component 1 mmc1

Supplementary MaterialsMultimedia component 1 mmc1. cell. Multiple hormone cells are recognized by different shades. pancreas. Each dot represents an individual cell sample. The colors denote the cell treatment and type condition. expression (appearance Slc16a3 ([15] and [50] transgenic mice had been found in this research. Male mice had been weaned to regular chow at postnatal time 21 (P21). Every one of the techniques were approved by the Institutional Animal Make use of and Treatment Committee of Peking School. 2.2. In?vivo STZ treatment STZ was dissolved in 50?mM sodium citrate buffer (pH 4.5) and injected within 15?min of preparation. Two-month-old male mice were injected intraperitoneally with a single high dose of STZ (200?mg/kg, V900890, Sigma) after an over night fast. The control mice were injected with an equal volume of sodium citrate buffer. 2.3. Insulin treatment and blood glucose monitoring To prevent death in long-term experiments, the mice received subcutaneous insulin implants (LinBit Pr-1-B, LinShin Canada) when hyperglycemic ( 400?mg/dL). The first insulin implant was given 2 days after STZ injection. Non-fasted blood glucose levels were determined from your tail vein using a Contour Next blood AescinIIB glucose meter. 2.4. Insulin secretion assay Eight-week-old male C57BL/6 mice were injected with STZ as previously explained. Three or six days after STZ treatment, blood was collected AescinIIB from STZ-treated and control mice after fasting for 6?hours. Fasting serum insulin levels were determined using a Rat/Mouse Insulin ELISA Kit (EZRMI-13K, Millipore) according to the manufacturer’s instructions. 2.5. Fluorescence-activated cell sorting (FACS) The pancreas was perfused and digested using 0.5?mg/mL collagenase P (11213873001, Roche) as previously reported [16]. After centrifugation and removal of the supernatant, pancreatic cells was dissociated into solitary cells via 0.25% trypsin-EDTA treatment for 5?min?at 37?C, and digestion was terminated with 0.4 volumes of fetal bovine serum (FBS). The cells were sorted using a BD FACS Aria AescinIIB SORP cell sorter. 2.6. Single-cell RNA-seq Library preparation was conducted following a modified STRT-seq protocol [17,18]. Briefly, after cell sorting, solitary Ngn3-Cre; Rosa-RFPcells were transferred quickly into lysis buffer by a mouth pipette. Next, we reverse-transcribed the RNA and amplified the producing AescinIIB cDNA over 18 cycles of PCR. The quality of the cDNA was assessed by qPCR of the housekeeping gene mice were acquired by FACS. Total RNA from sorted cells was prepared using an RNAprep Pure Kit (for micro samples) (DP420, Tiangen). First-strand cDNA was synthesized using HiScript II Q RT SuperMix (R223, Vazyme). Real-time AescinIIB PCR was performed with 2X M5 HiPer SYBR Premix EsTaq (MF787-01, Mei5 Biotechnology). The following primer sequences were used for RT-qPCR: and and mice to enrich RFP+ pancreatic endocrine cells (Number?1ACD). The mice were treated with a single high dose (200?mg/kg) of STZ and were assessed from day time 6 (D6) to month 9 (M9) (Number?1A). At D1 after STZ treatment, we observed an impaired islet structure, with many INS+ cells diminished (Supplementary Number?S1A). At D3 and D6, body weight significantly decreased, and the treated mice exhibited severe hyperglycemia and significantly reduced insulin concentrations compared with the control organizations (Supplementary Number?S1B). These results indicated the -cells were significantly damaged in our STZ model. In this study, only mice with hyperglycemia at D2 after STZ treatment were used for subsequent experiments (Supplementary Number?S1C). To prevent the mice from dying from intense hyperglycemia and study the cell claims over a longer time period, we subcutaneously implanted an insulin capsule at D2 after STZ treatment [13]. We measured non-fasting blood glucose at 4 p.m. every three days and implanted insulin pellets when hyperglycemia ( 400?mg/dL) was detected. The blood glucose level remained below 400?mg/dL after insulin implantation, but the mice without implantation remained hyperglycemic ( 600?mg/dL) and subsequently died (Supplementary Number?S1D). However, two mice that did not receive an insulin supply but survived at M2 after.